Martin Lord

644 total citations
28 papers, 341 citations indexed

About

Martin Lord is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Oncology. According to data from OpenAlex, Martin Lord has authored 28 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Martin Lord's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Medical Imaging Techniques and Applications (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Martin Lord is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Medical Imaging Techniques and Applications (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Martin Lord collaborates with scholars based in Sweden, Canada and United Kingdom. Martin Lord's co-authors include J.-M. Lavoie, A. Gourévitch, Lindvi Gudmundsdotter, Stefan Ståhl, Jean‐Paul Vallée, Sara M. Mangsbo, Magdalena Malm, Fredrik Y. Frejd, John Löfblom and Agata M. Wasik and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Martin Lord

27 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Lord Sweden 11 127 102 76 65 54 28 341
Peter Geyer Germany 9 134 1.1× 86 0.8× 147 1.9× 43 0.7× 69 1.3× 26 390
Beata Biesaga Poland 12 108 0.9× 130 1.3× 114 1.5× 59 0.9× 127 2.4× 43 392
Nikolai Jaschke Germany 11 70 0.6× 96 0.9× 60 0.8× 53 0.8× 94 1.7× 25 375
Isao Mori Japan 7 87 0.7× 127 1.2× 55 0.7× 66 1.0× 64 1.2× 13 324
Jialu Yao China 9 85 0.7× 142 1.4× 41 0.5× 116 1.8× 23 0.4× 26 582
A. S. Michalowski United Kingdom 11 326 2.6× 118 1.2× 168 2.2× 70 1.1× 55 1.0× 19 534
Ying Deng China 12 126 1.0× 136 1.3× 60 0.8× 46 0.7× 71 1.3× 58 457
Elisa Bordón Spain 15 169 1.3× 169 1.7× 100 1.3× 48 0.7× 172 3.2× 20 450
Xiaowen Ge China 11 82 0.6× 81 0.8× 67 0.9× 31 0.5× 86 1.6× 22 385
Liesl S. Eibschutz United States 9 76 0.6× 99 1.0× 34 0.4× 24 0.4× 54 1.0× 21 317

Countries citing papers authored by Martin Lord

Since Specialization
Citations

This map shows the geographic impact of Martin Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Lord more than expected).

Fields of papers citing papers by Martin Lord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Lord. The network helps show where Martin Lord may publish in the future.

Co-authorship network of co-authors of Martin Lord

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Lord. A scholar is included among the top collaborators of Martin Lord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Lord. Martin Lord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akpinar, Gözde Güçlüler, Martin Lord, Juan Astorga‐Wells, et al.. (2024). A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T Cell proliferation and anti-tumor immunity in mice. Nature Communications. 15(1). 9542–9542. 2 indexed citations
2.
Gunasekera, Sunithi, Taj Muhammad, Mingshu Zhang, et al.. (2023). Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS‐COV‐2 Antibodies. ChemBioChem. 24(15). e202300103–e202300103. 1 indexed citations
3.
Türker, Polat, Per‐Uno Malmström, Artur Mezheyeuski, et al.. (2023). Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer. BMC Cancer. 23(1). 605–605. 7 indexed citations
4.
5.
Mangsbo, Sara M., Sebastian Havervall, Robin S. Lindsay, et al.. (2021). An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses. PLoS ONE. 16(9). e0258041–e0258041. 5 indexed citations
6.
Dahllund, Leif, Helena Persson, Anders Olsson, et al.. (2021). Fed-batch production assessment of a tetravalent bispecific antibody: A case study on piggyBac stably transfected HEK293 cells. New Biotechnology. 65. 9–19. 15 indexed citations
7.
Lord, Martin, Xiaojie Yu, Mark S. Cragg, et al.. (2020). Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients. International Immunopharmacology. 90. 107226–107226. 7 indexed citations
8.
Lord, Martin, et al.. (2020). The use of 18F-FDG PET/CT to guide management of adrenal histoplasmosis over time. European Journal of Nuclear Medicine and Molecular Imaging. 48(4). 1250–1251. 1 indexed citations
9.
Bahig, Houda, Marie‐Pierre Campeau, Stéphane Bedwani, et al.. (2017). Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning. International Journal of Radiation Oncology*Biology*Physics. 99(2). 334–343. 21 indexed citations
10.
Provost, Karine, et al.. (2017). Reproducibility of Lobar Perfusion and Ventilation Quantification Using SPECT/CT Segmentation Software in Lung Cancer Patients. Journal of Nuclear Medicine Technology. 45(3). 185–192. 11 indexed citations
11.
Graham, François, Martin Lord, Daniel Froment, Héloïse Cardinal, & Guillaume Bollée. (2015). The use of gallium-67 scintigraphy in the diagnosis of acute interstitial nephritis. Clinical Kidney Journal. 9(1). 76–81. 22 indexed citations
12.
Perrot, Thomas de, Olivier Rager, Max Scheffler, et al.. (2014). Potential of hybrid 18F-fluorocholine PET/MRI for prostate cancer imaging. European Journal of Nuclear Medicine and Molecular Imaging. 41(9). 1744–1755. 35 indexed citations
13.
Malm, Magdalena, Lindvi Gudmundsdotter, Martin Lord, et al.. (2014). Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin‐binding domain allows for affinity purification and in vivo half‐life extension. Biotechnology Journal. 9(9). 1215–1222. 48 indexed citations
14.
15.
Wasik, Agata M., Martin Lord, Xiao Wang, et al.. (2013). SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression. Scientific Reports. 3(1). 1400–1400. 26 indexed citations
16.
Lord, Martin, M. Allaoua, & Osman Ratib. (2011). Positron emission tomography findings in systemic juvenile idiopathic arthritis. Lara D. Veeken. 50(6). 1177–1177. 4 indexed citations
17.
Lord, Martin, Osman Ratib, & Jean‐Paul Vallée. (2011). 18F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 38(12). 2288–2288. 9 indexed citations
18.
Lord, Martin & A. Gourévitch. (1965). The peritoneal anatomy of the spleen, with special reference to the operation of partial gastrectomy. British journal of surgery. 52(3). 202–204. 18 indexed citations
19.
Lord, Martin. (1962). LARGE-BOWEL CANCER: AN IMMUNOLOGICAL STUDY. The Lancet. 280(7260). 811–812. 8 indexed citations
20.
Lord, Martin. (1959). A case of abdomino-scrotal hydrocele hydrocèle en bissac. British journal of surgery. 46(200). 645–646. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Geyer Breakdown of academic impact, for papers by Beata Biesaga Breakdown of academic impact, for papers by Nikolai Jaschke Breakdown of academic impact, for papers by Isao Mori Breakdown of academic impact, for papers by Jialu Yao Breakdown of academic impact, for papers by A. S. Michalowski Breakdown of academic impact, for papers by Ying Deng Breakdown of academic impact, for papers by Elisa Bordón Breakdown of academic impact, for papers by Xiaowen Ge Breakdown of academic impact, for papers by Liesl S. Eibschutz
Rankless by CCL
2026